Miguel Botto

CBRA Genomics SA provides medical research and development services. The firm focuses on the development and commercialization of clinical decision-support tools based on a patient's whole-genome sequencing. It also offers research and development services for genomics of gastric cancer. The company was founded in 2012 by Carlos Fiolhais, Carlos José Fialho da Costa Faro, Manuel Gonçalo Lopes de Almeida Quadros, Marco Costa and Nuno Arantes-Oliveira and is headquartered in Cantanhede, Portugal.

Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal.

Stemmatters - Biotecnologia e Medicina Regenerativa SA develops biomaterials, medical devices and advanced therapy medicinal products. It focuses on tissue engineering and regenerative medicine. The firm also provides contract manufacturing services regarding tissue processing, manufacturing (cells and cell based products), and stem cell banking. The company was founded by Rui Amandi Sousa and Rui L. Reis in 2007 and is headquartered in Guimarães, Portugal.

CBRA Genomics SA provides medical research and development services. The firm focuses on the development and commercialization of clinical decision-support tools based on a patient's whole-genome sequencing. It also offers research and development services for genomics of gastric cancer. The company was founded in 2012 by Carlos Fiolhais, Carlos José Fialho da Costa Faro, Manuel Gonçalo Lopes de Almeida Quadros, Marco Costa and Nuno Arantes-Oliveira and is headquartered in Cantanhede, Portugal.

Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal.

Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal.

Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal.

CBRA Genomics SA provides medical research and development services. The firm focuses on the development and commercialization of clinical decision-support tools based on a patient's whole-genome sequencing. It also offers research and development services for genomics of gastric cancer. The company was founded in 2012 by Carlos Fiolhais, Carlos José Fialho da Costa Faro, Manuel Gonçalo Lopes de Almeida Quadros, Marco Costa and Nuno Arantes-Oliveira and is headquartered in Cantanhede, Portugal.

Stemmatters - Biotecnologia e Medicina Regenerativa SA develops biomaterials, medical devices and advanced therapy medicinal products. It focuses on tissue engineering and regenerative medicine. The firm also provides contract manufacturing services regarding tissue processing, manufacturing (cells and cell based products), and stem cell banking. The company was founded by Rui Amandi Sousa and Rui L. Reis in 2007 and is headquartered in Guimarães, Portugal.